The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a rapidly evolving pandemic worldwide with at least 68 million COVID-19-positive cases and a mortality rate of about 2.2%, as of 10 December 2020. In about 20% of COVID-19 instances, the disease exhibits moderate to severe symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Features, Evaluation and Treatment Coronavirus (COVID-19)
Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020) · StatPearls · Cited by 5,180
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Velavan, T. P., & Meyer, C. G. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13383 · Cited by 2,439
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
Whittaker, E., Bamford, A., Kenny, J., Kaforou, M., Jones, C. E., Shah, P., Ramnarayan, P., Fraisse, A., Miller, O., Davies, P., et al. (2020) · JAMA · doi:10.1001/jama.2020.10369 · Cited by 1,994
Multiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“spleen, intestine, brain, and blood (54, 55).”
The cytokine storm and COVID-19
Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Li, M.-Y., Li, L., Zhang, Y., & Wang, X.-S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00662-x · Cited by 1,583
The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 Transcription Factor Activation
Zhong, B., Yang, Y., Li, S., Wang, Y.-Y., Li, Y., Diao, F., Lei, C., He, X., Zhang, L., Tien, P., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.003 · Cited by 1,519
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459
Hung, I. F.-N., Lung, K.-C., Tso, E. Y.-K., Liu, R., Chung, T. W.-H., Chu, M.-Y., Ng, Y.-Y., Lo, J., Chan, J., Tam, A. R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31042-4 · Cited by 1,455
Adult haemophagocytic syndrome
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,442
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
Coronavirus disease 2019 (COVID-19): A literature review
Harapan, H., Itoh, N., Yufika, A., Winardi, W., Keam, S., Te, H., Megawati, D., Hayati, Z., Wagner, A. L., & Mudatsir, M. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.03.019 · Cited by 1,418
Cancer immunotherapy: harnessing the immune system to battle cancer
Yang, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83871 · Cited by 1,359
Gandhi, R. T., Lynch, J. B., & del Rio, C. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009249 · Cited by 1,307
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020) · Aging · doi:10.18632/aging.103000 · Cited by 1,304
Sungnak, W., Huang, N., Bécavin, C., & Berg, M. (2020) · PubMed Central · Cited by 1,196
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H., Ling, Y., Jiang, Y., & Shi, Y. (2020) · Radiology · doi:10.1148/radiol.2020200274 · Cited by 1,190
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Shin, D., Mukherjee, R., Grewe, D., Bojkova, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A. R., Tascher, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2601-5 · Cited by 1,177
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03120-0 · Cited by 1,175
COVID-19: combining antiviral and anti-inflammatory treatments
Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Activation and evasion of type I interferon responses by SARS-CoV-2
Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17665-9 · Cited by 980
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Evasion of Type I Interferon by SARS-CoV-2
Xia, H., Cao, Z., Xie, X., Zhang, X., Chen, J. Y.-C., Wang, H., Menachery, V. D., Rajsbaum, R., & Shi, P.-Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108234 · Cited by 957
Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 940
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Guaraldi, G., Meschiari, M., Cozzi-Lepri, A., Milic, J., Tonelli, R., Menozzi, M., Franceschini, E., Cuomo, G., Orlando, G., Borghi, V., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30173-9 · Cited by 939
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens-Kiani, T., Cheng, J., et al. (2020) · Science · doi:10.1126/science.abc8665 · Cited by 881
Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Lee, J. S., Park, S., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J.-S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 825
Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., & Kishimoto, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.332 · Cited by 783
Otter, J. A., Donskey, C., Yezli, S., Douthwaite, S., Goldenberg, S. D., & Weber, D. J. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.08.027 · Cited by 780
Central nervous system manifestations of COVID-19: A systematic review
Asadi-Pooya, A. A., & Simani, L. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116832 · Cited by 774
Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia
Pei, G., Zhang, Z., Peng, J., Liu, L., Zhang, C., Yu, C., Ma, Z., Huang, Y., Liu, W., Yao, Y., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030276 · Cited by 767
Angiotensin II revisited: new roles in inflammation, immunology and aging
Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757 · cited 1×
“In endothelial cells, angiotensin II increases the expression of cell adhesion molecules, P-selectin, and L-selectin, involved in cellular homeostasis and inflammation (84).”
BackgroundJamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
Anakinra for severe forms of COVID-19: a cohort study
Huet, T., Beaussier, H., Voisin, O., Jouveshomme, S., Dauriat, G., Lazareth, I., Sacco, E., Naccache, J.-M., Bézie, Y., Laplanche, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30164-8 · Cited by 643
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis
Zhu, J., Ji, P., Pang, J., Zhong, Z., Li, H., He, C., Zhang, J., & Zhao, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25884 · Cited by 625
Huang, I.-C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001258 · Cited by 603
Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582
COVID-19 Disease due to SARS-CoV-2 (Novel Coronavirus)
Carlos, W. G., Dela Cruz, C. S., Cao, B., Pasnick, S., & Jamil, S. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2014p7 · Cited by 581
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Yuen, C.-K., Lam, J.-Y., Wong, W.-M., Mak, L.-F., Wang, X., Chu, H., Cai, J.-P., Jin, D.-Y., To, K. K.-W., Chan, J. F.-W., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1780953 · Cited by 524
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., et al. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.002 · Cited by 513 · cited 1×
“The overt induction of inflammatory cytokines that lead to inflammation and tissue injury during COVID-19 suggests that the suppression of inflammatory cytokines or their signaling pathway could help recovery and reduce mortality (23, 53) (Fig.”
BackgroundKawasaki-like disease: emerging complication during the COVID-19 pandemic
Viner, R. M., & Whittaker, E. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31129-6 · Cited by 503
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020) · Journal of Virology · doi:10.1128/jvi.01410-20 · Cited by 483
Davies, P., Evans, C., Kanthimathinathan, H. K., Lillie, J., Brierley, J., Waters, G., Johnson, M., Griffiths, B., du Pré, P., Mohammad, Z., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30215-7 · Cited by 475
Fan, E., Beitler, J. R., Brochard, L., Calfee, C. S., Ferguson, N. D., Slutsky, A. S., & Brodie, D. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30304-0 · Cited by 473
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
Bailey, C. C., Zhong, G., Huang, I.-C., & Farzan, M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085537 · Cited by 467
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Li, J.-Y., Liao, C.-H., Wang, Q., Tan, Y.-J., Luo, R., Qiu, Y., & Ge, X.-Y. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198074 · Cited by 461
Multiple Enzymatic Activities Associated with Severe Acute Respiratory Syndrome Coronavirus Helicase
Ivanov, K. A., Thiel, V., Dobbe, J. C., van der Meer, Y., Snijder, E. J., & Ziebuhr, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5619-5632.2004 · Cited by 435
Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., Nakagawa, S., & Sato, K. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108185 · Cited by 433
Antiviral activities of type I interferons to SARS-CoV-2 infection
Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S., & Huang, C. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104811 · Cited by 426
The type I interferon response in COVID-19: implications for treatment
Lee, J. S., & Shin, E.-C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00429-3 · Cited by 421
Interferon-α2b Treatment for COVID-19
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01061 · Cited by 417
Smith, J. C., Sausville, E. L., Girish, V., Yuan, M. L., Vasudevan, A., John, K. M., & Sheltzer, J. M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.012 · Cited by 415
Causes of death and comorbidities in hospitalized patients with COVID-19
Elezkurtaj, S., Greuel, S., Ihlow, J., Michaelis, E. G., Bischoff, P., Kunze, C. A., Sinn, B. V., Gerhold, M., Hauptmann, K., Ingold-Heppner, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82862-5 · Cited by 413
Wang, C., Xie, J., Zhao, L., Fei, X., Zhang, H., Tan, Y., Nie, X., Zhou, L., Liu, Z., Ren, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102833 · Cited by 412
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Age- and gender-related difference of ACE2 expression in rat lung
Xudong, X., Junzhu, C., Xingxiang, W., Furong, Z., & Yanrong, L. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.09.038 · Cited by 410 · cited 1×
“In rats, ACE2 expression decreased with aging, and no significant gender differences exist between young and middle-aged rats in the levels of ACE2, although a higher ACE2 level was noted in the older female rats than in male rats (78).”
BackgroundAre pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
Liu, P., Jiang, J.-Z., Wan, X.-F., Hua, Y., Li, L., Zhou, J., Wang, X., Hou, F., Chen, J., Zou, J., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008421 · Cited by 410
Interleukin (IL-6) Immunotherapy
Tanaka, T., Narazaki, M., & Kishimoto, T. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028456 · Cited by 407
Viral and cellular mRNA capping: Past and prospects
Furuichi, Y., & Shatkin, A. J. (2000) · Advances in Virus Research · doi:10.1016/s0065-3527(00)55003-9 · Cited by 404
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Pinto, B. G. G., Oliveira, A. E. R., Singh, Y., Jimenez, L., Gonçalves, A. N. A., Ogava, R. L. T., Creighton, R., Schatzmann Peron, J. P., & Nakaya, H. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa332 · Cited by 391
Deng, X., Hackbart, M., Mettelman, R. C., O’Brien, A., Mielech, A. M., Yi, G., Kao, C. C., & Baker, S. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618310114 · Cited by 386
Aggarwal, S., Garcia-Telles, N., Aggarwal, G., Lavie, C., Lippi, G., & Henry, B. M. (2020) · Diagnosis · doi:10.1515/dx-2020-0046 · Cited by 377
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Feng, Z., Diao, B., Wang, R., Wang, G., Wang, C., Tan, Y., Liu, L., Wang, C., Liu, Y., Liu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.27.20045427 · Cited by 362
Huang, J., Hume, A. J., Abo, K. M., Werder, R. B., Villacorta-Martin, C., Alysandratos, K.-D., Beermann, M. L., Simone-Roach, C., Lindstrom-Vautrin, J., Olejnik, J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.013 · Cited by 338
Harwood, R., Allin, B., Jones, C. E., Whittaker, E., Ramnarayan, P., Ramanan, A. V., Kaleem, M., Tulloh, R., Peters, M. J., Almond, S., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30304-7 · Cited by 336
Extra-respiratory manifestations of COVID-19
Lai, C.-C., Ko, W.-C., Lee, P.-I., Jean, S.-S., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106024 · Cited by 330
MacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3548-0 · Cited by 323
Braun‐Falco, M., Kovnerystyy, O., Lohse, P., & Ruzicka, T. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.025 · Cited by 318
Castaño-Rodriguez, C., Honrubia, J. M., Gutiérrez-Álvarez, J., DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Verdia-Báguena, C., Queralt-Martín, M., et al. (2018) · mBio · doi:10.1128/mbio.02325-17 · Cited by 313
Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases
Clementz, M. A., Chen, Z., Banach, B. S., Wang, Y., Sun, L., Ratia, K., Baez-Santos, Y. M., Wang, J., Takayama, J., Ghosh, A. K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02406-09 · Cited by 308
Davoudi-Monfared, E., Rahmani, H., Khalili, H., Hajiabdolbaghi, M., Salehi, M., Abbasian, L., Kazemzadeh, H., & Yekaninejad, M. S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01061-20 · Cited by 306
Hu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X., & Cao, C. (2017) · Journal of Virology · doi:10.1128/jvi.02143-16 · Cited by 294
Anakinra Therapy for Non-cancer Inflammatory Diseases
Cavalli, G., & Dinarello, C. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01157 · Cited by 292
How tumour necrosis factor blockers interfere with tuberculosis immunity
Harris, J., & Keane, J. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04146.x · Cited by 291
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
Schaefer, I.-M., Padera, R. F., Solomon, I. H., Kanjilal, S., Hammer, M. M., Hornick, J. L., & Sholl, L. M. (2020) · Modern Pathology · doi:10.1038/s41379-020-0595-z · Cited by 285
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
Remmelink, M., De Mendonça, R., D’Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trépant, A.-L., Maris, C., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03218-5 · Cited by 284
Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., & Jin, D.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008227 · Cited by 272
Chen, X., Yang, X., Zheng, Y., Yang, Y., Xing, Y., & Chen, Z. (2014) · Protein & Cell · doi:10.1007/s13238-014-0026-3 · Cited by 272
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Neufeldt, C. J., Cerikan, B., Cortese, M., Frankish, J., Lee, J.-Y., Plociennikowska, A., Heigwer, F., Prasad, V., Joecks, S., Burkart, S. S., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02983-5 · Cited by 272
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
Dayer, J.-M., & Choy, E. (2010) · Rheumatology · doi:10.1093/rheumatology/kep329 · Cited by 267
Type I IFN immunoprofiling in COVID-19 patients
Trouillet-Assant, S., Viel, S., Gaymard, A., Pons, S., Richard, J.-C., Perret, M., Villard, M., Brengel-Pesce, K., Lina, B., Mezidi, M., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.029 · Cited by 265
Decroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K., Gorbalenya, A. E., Snijder, E. J., & Canard, B. (2008) · Journal of Virology · doi:10.1128/jvi.00407-08 · Cited by 252
Wang, W., Ye, L., Ye, L., Li, B., Gao, B., Zeng, Y., Kong, L., Fang, X., Zheng, H., Wu, Z., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.007 · Cited by 247
Chen, M., Shen, W., Rowan, N. R., Kulaga, H., Hillel, A., Ramanathan, M., & Lane, A. P. (2020) · European Respiratory Journal · doi:10.1183/13993003.01948-2020 · Cited by 246
Angiotensin-converting enzyme in innate and adaptive immunity
Bernstein, K. E., Khan, Z., Giani, J. F., Cao, D.-Y., Bernstein, E. A., & Shen, X. Z. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.15 · Cited by 241
Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
Shi, G., Kenney, A. D., Kudryashova, E., Zani, A., Zhang, L., Lai, K. K., Hall‐Stoodley, L., Robinson, R. T., Kudryashov, D. S., Compton, A. A., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106501 · Cited by 240
SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death
Yue, Y., Nabar, N. R., Shi, C.-S., Kamenyeva, O., Xiao, X., Hwang, I.-Y., Wang, M., & Kehrl, J. H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0917-y · Cited by 231
COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
Ciaglia, E., Vecchione, C., & Puca, A. A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00206 · Cited by 231
Aouba, A., Baldolli, A., Geffray, L., Verdon, R., Bergot, E., Martin-Silva, N., & Justet, A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217706 · Cited by 228
Functional landscape of SARS-CoV-2 cellular restriction
Martin-Sancho, L., Lewinski, M. K., Pache, L., Stoneham, C. A., Yin, X., Becker, M. E., Pratt, D., Churas, C., Rosenthal, S. B., Liu, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.008 · Cited by 216
Menachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.03571-13 · Cited by 212
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
Conceicao, C., Thakur, N., Human, S., Kelly, J. T., Logan, L., Bialy, D., Bhat, S., Stevenson-Leggett, P., Zagrajek, A. K., Hollinghurst, P., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3001016 · Cited by 210
Gritti, G., Raimondi, F., Bottazzi, B., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., Frigeni, M., Damiani, M., Micò, C., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01299-x · Cited by 210
Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
Zhang, K., Miorin, L., Makio, T., Dehghan, I., Gao, S., Xie, Y., Zhong, H., Esparza, M., Kehrer, T., Kumar, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe7386 · Cited by 209
Stebbing, J., Sánchez Nievas, G., Falcone, M., Youhanna, S., Richardson, P., Ottaviani, S., Shen, J. X., Sommerauer, C., Tiseo, G., Ghiadoni, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4724 · Cited by 207
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Kircheis, R., Haasbach, E., Lueftenegger, D., Heyken, W. T., Ocker, M., & Planz, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.598444 · Cited by 201
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Cauchois, R., Koubi, M., Delarbre, D., Manet, C., Carvelli, J., Blasco, V. B., Jean, R., Fouche, L., Bornet, C., Pauly, V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009017117 · Cited by 199
Sohn, K. M., Lee, S.-G., Kim, H. J., Cheon, S., Jeong, H., Lee, J., Kim, I. S., Silwal, P., Kim, Y. J., Paik, S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e343 · Cited by 199
SARS coronavirus accessory proteins
Narayanan, K., Huang, C., & Makino, S. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.009 · Cited by 198
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
Zhao, X., Guo, F., Liu, F., Cuconati, A., Chang, J., Block, T. M., & Guo, J.-T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320856111 · Cited by 191
Shu, T., Huang, M., Wu, D., Ren, Y., Zhang, X., Han, Y., Mu, J., Wang, R., Qiu, Y., Zhang, D.-Y., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00242-1 · Cited by 187
Zhang, X., Zhang, Y., Qiao, W., Zhang, J., & Qi, Z. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106749 · Cited by 182
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
Abassi, Z., Knaney, Y., Karram, T., & Heyman, S. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01312 · Cited by 179
Yang, D., Chu, H., Hou, Y., Chai, Y., Shuai, H., Lee, A. C.-Y., Zhang, X., Wang, Y., Hu, B., Huang, X., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa356 · Cited by 179
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
Chang, D., Mo, G., Yuan, X., Tao, Y., Peng, X., Wang, F.-S., Xie, L., Sharma, L., Dela Cruz, C. S., & Qin, E. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0524le · Cited by 178
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Cantini, F., Niccoli, L., Nannini, C., Matarrese, D., Natale, M. E. D., Lotti, P., Aquilini, D., Landini, G., Cimolato, B., Pietro, M. A. D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.052 · Cited by 174
Shah, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01021 · Cited by 168
We shouldn’t worry when a virus mutates during disease outbreaks
Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 167
Çevik, M., Marcus, J. L., Buckee, C. O., & Smith, T. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1442 · Cited by 164
Interferon and cytokine responses to SARS-coronavirus infection
Thiel, V., & Weber, F. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.001 · Cited by 160
Winstone, H., Lista, M. J., Reid, A. C., Bouton, C. R., Pickering, S., Galão, R. P., Kerridge, C., Doores, K. J., Swanson, C. M., & Neil, S. J. D. (2021) · Journal of Virology · doi:10.1128/jvi.02422-20 · Cited by 147
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Lee, W., Ahn, J. H., Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00292-7 · Cited by 143
Chen, I.-Y., Chang, S. C., Wu, H.-Y., Yu, T.-C., Wei, W.-C., Lin, S., Chien, C.-L., & Chang, M.-F. (2010) · Journal of Virology · doi:10.1128/jvi.02560-09 · Cited by 141 · cited 6×
“angiotensin II/AT1R pathway (16, 70); (ii) the ACE2 signaling pathway (71, 72); and (iii) the”
BackgroundMethodInfluentialmRNA Cap-1 Methyltransferase in the SARS Genome
von Grotthuss, M., Wyrwicz, L. S., & Rychlewski, L. (2003) · Cell · doi:10.1016/s0092-8674(03)00424-0 · Cited by 140
Chang, Y., Liu, C. Y. Y., Chiang, B., Chao, Y., & Chen, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7602 · Cited by 136
Taylor, J. K., Coleman, C. M., Postel, S., Sisk, J. M., Bernbaum, J. G., Venkataraman, T., Sundberg, E. J., & Frieman, M. B. (2015) · Journal of Virology · doi:10.1128/jvi.02274-15 · Cited by 136
Recinos, A., LeJeune, W. S., Sun, H., Lee, C. Y., Tieu, B. C., Lu, M., Hou, T., Boldogh, I. R., Tilton, R. G., & Brasier, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.013 · Cited by 135
Robinson, P. C., Richards, D. B., Tanner, H. L., & Feldmann, M. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30309-x · Cited by 131
The interplay between Angiotensin II, TLR4 and hypertension
Biancardi, V. C., Bomfim, G. F., Reis, W. L., Al-Gassimi, S., & Nunes, K. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.017 · Cited by 129
Age and sex differences in soluble ACE2 may give insights for COVID-19
Swärd, P., Edsfeldt, A., Reepalu, A., Jehpsson, L., Rosengren, B. E., & Karlsson, M. K. (2020) · Critical Care · doi:10.1186/s13054-020-02942-2 · Cited by 128
COVID-19 pneumonia and the appropriate use of antibiotics
Ginsburg, A. S., & Klugman, K. P. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30444-7 · Cited by 125
Yamamoto, S., Yancey, P. G., Zuo, Y., Ma, L.-J., Kaseda, R., Fogo, A. B., Ichikawa, I., Linton, M. F., Fazio, S., & Kon, V. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237198 · Cited by 123
Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending
Onofrio, L., Caraglia, M., Facchini, G., Margherita, V., Placido, S. D., & Buonerba, C. (2020) · Future Science OA · doi:10.2144/fsoa-2020-0091 · Cited by 121
To sense or not to sense viral RNA—essentials of coronavirus innate immune evasion
Kindler, E., & Thiel, V. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.05.005 · Cited by 113
Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
Miller, E. A., & Ernst, J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39143 · Cited by 113
Bénéteau‐Burnat, B., Baudin, B., Morgant, G., Baumann, F. C., & GIBOUDEAU, J. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.2.344 · Cited by 103
Activation of NF-κB by the Full-length Nucleocapsid Protein of the SARS Coronavirus
Liao, Q., Ye, L.-B., Timani, K. A., Zen, Y., She, Y., Li, Y., & Wu, Z.-H. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2005.00082.x · Cited by 98
Dai, Q., Xu, M., Yao, M., & Sun, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707454 · Cited by 90
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka‐Winiarska, V., Grywalska, E., & Roliński, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01682-y · Cited by 87
Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients
Saleh, A. A. G., Sultan, A., Elashry, M. A., Farag, A., Mortada, M. I., Ghannam, M. A., Saed, A. M., & Ghoneem, E. A. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1851709 · Cited by 85
Masiá, M., Fernández‐González, M., Padilla, S., Ortega, P., García, J. A., Agulló, V., García‐Abellán, J., Telenti, G., Guillén, L., & Gutiérrez, F. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102999 · Cited by 81
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
Mihara, M., Ohsugi, Y., & Kishimoto (2011) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s17118 · Cited by 80
Min, Y., Mo, Q., Wang, J., Dèng, F., Wáng, H., & Ning, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587317 · Cited by 79
Zheng, B., He, M., Wong, K.-L., Lum, C. T., Poon, L. L. M., Peng, Y., Guan, Y., Lin, M. C. M., & Kung, H. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041535610 · Cited by 77
Yuan, Y., Luo, L., Guo, Z., Yang, M. J., Ye, R.-S., & Luo, C. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315576256 · Cited by 74
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint
Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 73
Ding, Z., Fang, L., Yuan, S., Zhao, L., Wang, X., Long, S., Wang, M., Wang, D., Foda, M. F., & Xiao, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17912 · Cited by 59
Ulhaq, Z. S., & Soraya, G. V. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.07.002 · Cited by 59
Opportunistic bacterial, viral and fungal infections of the lung
José, R. J. P., & Brown, J. (2016) · Medicine · doi:10.1016/j.mpmed.2016.03.015 · Cited by 58
Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity
Case, J. B., Li, Y., Elliott, R., Lu, X., Graepel, K. W., Sexton, N. R., Smith, E. C., Weiss, S. R., & Denison, M. R. (2017) · Journal of Virology · doi:10.1128/jvi.01531-17 · Cited by 58
Outbreak of COVID-19 in a nursing home in Madrid
Bouza, E., Pérez-Granda, M. J., Escribano, P., Fernández-del-Rey, R., Pastor, I., Moure, Z., Catalán, P., Alonso, R., Muñóz, P., & Guinea, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.055 · Cited by 53
Capochiani, E., Frediani, B., Iervasi, G., Paolicchi, A., Sani, S., Roncucci, P., Cuccaro, A., Franchi, F., Simonetti, F., Carrara, D., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00466 · Cited by 53
Wang, S.-M., Huang, K.-J., & Wang, C.-T. (2013) · Virology · doi:10.1016/j.virol.2013.11.030 · Cited by 49
Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
Gaspari, V., Zengarini, C., Greco, S., Vangeli, V., & Mastroianni, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106023 · Cited by 48
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
Ji, J., Zhang, J., Shao, Z., Xie, Q., Li, Z., & Liu, Z. (2020) · Critical Care · doi:10.1186/s13054-020-03287-6 · Cited by 46
Fernández‐Sarmiento, J., de Souza, D., Jabornisky, R., González, G., Lopez, M. D. P. A., & Palacio, G. (2021) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2020-000894 · Cited by 46
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
Stewart, H., Palmulli, R., Johansen, K. H., McGovern, N. N., Shehata, O. M., Carnell, G., Jackson, H. K., Lee, J. S., Brown, J. C., Burgoyne, T., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357224 · Cited by 40
A Review of Sarilumab for the Treatment of Rheumatoid Arthritis
Lee, E. B. (2017) · Immunotherapy · doi:10.2217/imt-2017-0075 · Cited by 36
Long, K. D., Woodburn, E. V., Berg, I. C., Chen, V., & Scott, W. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240499 · Cited by 25
Irvani, S. S. N., Golmohammadi, M., Pourhoseingholi, M. A., Shokouhi, S., & Darazam, I. A. (2020) · Trials · doi:10.1186/s13063-020-04382-3 · Cited by 21
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
Gozzetti, A., Capochiani, E., & Bocchia, M. (2020) · Leukemia · doi:10.1038/s41375-020-01038-8 · Cited by 20
Xue, J., Zheng, J., Shang, X., Qin, E., Zhao, P., He, Y., Liu, M., Zhang, J., Liu, H., & Bai, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107031 · Cited by 14
Molecular cloning, expression, and purification of SARS-CoV nsp13
Fan, Z., Peng, K., Tan, X., Yin, B., Dong, X., Qiu, F.-C., Shen, Y., Wang, H., Yuan, J., Qiang, B., et al. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2004.08.003 · Cited by 6
The Abstruse Side of Type I Interferon Immunotherapy for COVID-19 Cases with Comorbidities
Subbian, S. (2021) · Journal of Respiration · doi:10.3390/jor1010005 · Cited by 6
Self-citation
Cited by
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Redondo, N., Zaldívar-López, S., Garrido, J. J., & Montoya, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708264 · Cited by 299
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 281
Savin, I. A., Zenkova, M. A., & Sen’kova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314959 · Cited by 279
Tong, R., Luo, L., Zhao, Y., Sun, M., Li, R., Zhong, J., Chen, Y., Hu, L., Li, Z., Shi, J., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2187245 · Cited by 21
Metadata
- Authors
- Ramasamy, S., & Subbian, S.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2021-06-16
- Volume
- 34
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3160295311
- Cited by
- 289
- References
- 186
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.